Premature babies in the UK can now be protected against RSV with a single, long-lasting injection available on the NHS for ...

NHS England » NHS to roll out long-lasting ‘suit of armour’ jab to protect thousands of premature babies from RSV ...

Thousands of premature babies in the UK can now be protected against a common winter virus which can cause a dangerous lung ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

The new injection, Nirsevimab, will be given to high-risk babies, including those born too early to be protected by the RSV ...

Five risk factors explain 50 per cent of cardiovascular risk at age 50, according to a new study.  Addressing those risk factors can add years to your life, even if you address them in middle age. ...

RSV can lead to a severe lung infection called bronchiolitis, which is dangerous in babies and can result in them being admitted to intensive care. It is the main infectious cause of hospitalisation ...

Since the start of February, pregnant women have been eligible to get vaccinated against respiratory syncytial virus (RSV).  The vaccine is administered during the 28 to 36 week mark of pregnancy to ...

Researchers looked at the cases of 537 babies in England and Scotland who were admitted to hospital with severe respiratory ...

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new drug that protects against RSV, a common cold-like virus that can cause ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...